Health Sciences Acquisitions Corporation
Status: Closed Deal
U=S+W
W=S/2@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | May 10, 2019 |
| CEO | Roderick Wong, MD |
| Left Lead | Chardan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | North America/Europe |
| Target Company | Immunovant |
| Deal Announced | Oct 2, 2019 |
| Deal Size, $M | $555.75M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Dec 16, 2019 |
| Amendment Vote | TBD |
| Closing Date | Dec 18, 2019 |
Formerly HSAC
IMVT
IMVTW
| Price | $15.22 |
|---|---|
| Last closing price | $15.42 |
| H/L, today | $15.15 / $15.86 |
| H/L, 52-week | $10.62 / $44.19 |
| Volume, today | 1,213,705 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.